home · filing · 0001140361-24-023723
8-K
filed May 1, 2024, 7:59 PM ET
CIK 0001423774
leadership
confidence high
sentiment neutral
materiality 0.40
Zuora appoints John Harkey to board under cooperation agreement with Scalar Gauge
ZUORA INC
John D. Harkey Jr. appointed to Zuora Board as Class I director effective April 30, 2024.
Board expanded to 10 members, 9 independent; Harkey joins Compensation and Nominating/Governance committees.
Cooperation agreement with Scalar Gauge Fund (3.7% holder) includes standstill and voting provisions until 2025 annual meeting.
Harkey brings over 25 years experience as CEO, director, and private investor; co-founded AveXis (sold to Novartis).
Standstill limits Scalar Gauge to 9.9% max ownership and prohibits proxy solicitation during restricted period.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
John D. Harkey Jr.
Director
ZUORA INC
Effective 2024-04-30
Filed May 1, 2024, 7:59 PM ET
On April 30, 2024, the Board expanded the size of the Board to 10 members and appointed Mr. Harkey to the Board as a Class I director
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
John D. Harkey Jr. was appointed as Director at ZUORA INC.
Action appointed
Role Director
Exact text from the filing
On April 30, 2024, the Board expanded the size of the Board to 10 members and appointed Mr. Harkey to the Board as a Class I director
View on SEC.gov
Source: SEC EDGAR
accession 0001140361-24-023723
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.